Human gamma delta T-cell receptor (γδ TCR) (γδ TCR)

The human gamma delta (γδ) T-cell receptor is a heterodimeric antigen receptor composed of γ and δ polypeptide chains, primarily expressed on a distinct subset of T lymphocytes known as γδ T cells [PMID: 30111630]. Unlike conventional alpha-beta (αβ) T cells, γδ TCRs recognize a broad range of non-peptide antigens, such as phosphoantigens and stress-induced molecules, without the requirement for Major Histocompatibility Complex (MHC) presentation [PMID: 26027611]. This unique recognition mechanism allows γδ T cells to rapidly respond to cellular stress, infections, and transformed cells, serving as a critical link between innate and adaptive immunity [PMID: 31515470]. In therapeutic contexts, the γδ TCR is a high-priority target because its activation can trigger potent MHC-independent cytotoxicity against various solid and hematological tumors while maintaining a favorable safety profile regarding graft-versus-host disease [PMID: 32433938]. Current pharmacological strategies include the use of bispecific antibodies (Gammabodies) and monoclonal antibodies that stabilize the interaction between the TCR and its ligands, such as Butyrophilin 3A1 (BTN3A1), to selectively drive anti-tumor responses [PMID: 33106611].

Other names

Gamma delta T-cell receptorTCR gamma/deltaT-cell receptor gamma-delta complexTRG/TRD complex

Agonism or modulation of the receptor complex, often mediated through the stabilization of the TCR with butyrophilin proteins (e.g., BTN3A1), to trigger γδ T-cell activation, proliferation, and cytotoxic effector functions against target cells [PMID: 33106611, PMID: 32433938].